Follows people with resistant hypertension treated with the BAROSTIM NEO device
Observes people with hard-to-control high blood pressure who recently received the BAROSTIM NEO device.
Plain-language title generated from the registry record
Registry title: BAROSTIM THERAPY™ In Resistant Hypertension
Key facts
- Where
- Berlin, Bernau, Cloppenburg, Cologne, Detmold, Dresden, Erding, Frankfurt, Giessen, Göttingen, Hamburg, Hamm, Ingolstadt, Kiel, Lahr, Leipzig, Mainz, Papenburg, Regensburg, Siegen, Stadtlohn, Stuttgart, Tuttlingen, and Zwickau, GermanySee the 25 sites
Where in Germany
- Charité Benjamin FranklinBerlin, GermanyNo longer taking part
- Charite Campus VirchowBerlin, GermanyNo longer taking part
- Immanuel Klinikum Bernau Herzzentrum BrandenburgBernau, GermanyTaking people
- Cloppenburg Katholische Kliniken MünsterlandCloppenburg, GermanyNo longer taking part
- Universitätsklinikum Köln HerzzentrumCologne, GermanyTaking people
- Lippe KlinikumDetmold, GermanyTaking people
- Herzzentrum DresdenDresden, GermanyTaking people
- Krankenhaus ErdingErding, GermanyNo longer taking part
- Cardiovascular Center 'CVC' FrankfurtFrankfurt, GermanyTaking people
- Universitätsklinikum Gießen und MarburgGiessen, GermanyTaking people
- Herzzentrum GöttingenGöttingen, GermanyTaking people
- Asklepios Klinik AltonaHamburg, GermanyTaking people
- St. Barbara-Klinik HammHamm, GermanyNo longer taking part
- Kardiologie im Klinikum IngolstadtIngolstadt, GermanyTaking people
- Universitätsklinikum Schleswig-Holstein, Campus KielKiel, GermanyTaking people
- Herzentrum LahrLahr, GermanyNo longer taking part
- Universitatsklinikum LeipzigLeipzig, GermanyTaking people
- Universitätsklinik MainzMainz, GermanyNo longer taking part
- Papenburg Marien KrankenhausPapenburg, GermanyNo longer taking part
- Universitätsklinikum RegensburgRegensburg, GermanyTaking people
- Marienkrankenhaus SiegenSiegen, GermanyTaking people
- Krankenhaus & MVZ Maria-Hilf Stadtlohn GmbHStadtlohn, GermanyNo longer taking part
- Klinikum StuttgartStuttgart, GermanyTaking people
- Klinikum TuttlingenTuttlingen, GermanyTaking people
- Heinrich-Braun KlinikumZwickau, GermanyNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- CVRx, Inc.
- Trial code
- NCT02880631
- Record updated
- 11 September 2026
- Original description
The purpose of this registry (NCT02880631) is to evaluate the effect of BAROSTIM THERAPY with the BAROSTIM NEO System in the commercial setting in subjects recently implanted under the CE-Marked indication for resistant hypertension.Read full original descriptionShow less
BAROSTIM THERAPY™ In Resistant Hypertension: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
The purpose of this registry (NCT02880631) is to evaluate the effect of BAROSTIM THERAPY with the BAROSTIM NEO System in the commercial setting in subjects recently implanted under the CE-Marked indication for resistant hypertension.
Inclusion: Has signed an EC approved informed consent form; Has been implanted with the BAROSTIM NEO system in the past 30 days; Systolic blood pressure greater than or equal to 140 mmHg, and; Resistance to maximally tolerated therapy with a diuretic and two other anti-hypertension medications.
Exclusion: Baroreflex failure or autonomic neuropathy; Uncontrolled, symptomatic cardiac bradyarrhythmias; Bilateral carotid bifurcations located above the level of the mandible; Carotid atherosclerosis that is determined by ultrasound or angiographic evaluation to be greater than 50%; Ulcerative plaques in the carotid artery as determined by ultrasound or angiographic evaluation.